Nachrichten zur Atara Biotherapeutics Inc. Aktie

Atara (ATRA) Looks Good: Stock Adds 5.1% in Session

Atara (ATRA) saw a big move last session, as its shares jumped more than 5% on the day, amid huge…

Thinking about buying stock in CleanSpark, Atara Biotherapeutics, FuelCell Energy, Sorrento Therapeutics, or Plug Power?

NEW YORK , Sept. 11, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLSK,…

Atara Bio lead candidate shows sustained benefit in MS patients

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Atara Biotherapeutics Is Trading Higher Today

Atara Biotherapeutics (NASDAQ: ATRA) shares are trading higher on Wednesday on continued momentum from Tuesday after the FDA gave clearance…

Atara Biotherapeutics Inc (ATRA) Q2 2020 Earnings Call Transcript

ATRA earnings call for the period ending June 30, 2020....…

Atara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q2 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Atara Biotherapeutics, Inc. 2020 Q2 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Atara Biotherapeutics (ATRA) Might Surprise This Earnings Season

Atara Biotherapeutics (ATRA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings…

Atara Biotherapeutics (ATRA) Moves to Buy: Rationale Behind the Upgrade

Atara Biotherapeutics (ATRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects.…

Will Atara Biotherapeutics Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor of Atara Biotherapeutics...…

Is Atara Biotherapeutics (ATRA) Stock a Solid Choice Right Now?

Atara Biotherapeutics (ATRA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry…

Atara Biotherapeutics, Inc.: 8-K Report

8-K...…

Atara up 4% on advancement of ATA188 in MS study

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Atara Bio prices $175.5M equity offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Atara Bio launches equity offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Thinking about buying stock in Evofem Biosciences, Village Farms, Atara Biotherapeutics, Cronos Group, or American Airlines?

NEW YORK , May 26, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EVFM,…

Atara Bio rallies on new ATA188 data in multiple sclerosis

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Atara Bio (+11%) cell therapy shows promising action in MS study

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Thinking about buying stock in Atara Biotherapeutics, Anavex Life Sciences, Boxlight Corp, FuelCell Energy, or Upwork Inc-

NEW YORK , May 21, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATRA,…

Atara Biotherapeutics (ATRA) Moves to Strong Buy: Rationale Behind the Upgrade

Atara Biotherapeutics (ATRA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to…

Will Atara Biotherapeutics Continue to Surge Higher-

As of late, it has definitely been a great time to be an investor Atara Biotherapeutics...…

Atara Biotherapeutics, Inc. 2020 Q1 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Atara Biotherapeutics Inc (ATRA) Q1 2020 Earnings Call Transcript

ATRA earnings call for the period ending March 31, 2020....…

Atara Biotherapeutics Inc (ATRA) CEO Pascal Touchon on Q1 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Atara Biotherapeutics EPS beats by $0.23

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

2 Top-Biotech-Aktien, die unter 10 USD gehandelt werden

Amarin und Atara Biotherapeutics könnten Rohdiamanten sein. The post 2 Top-Biotech-Aktien, die unter 10 USD gehandelt werden appeared first on The…

Citi bullish on Atara Bio on prospects for lead drug; shares up 14%

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Atara Biotherapeutics: Still Bullish On Long-Term Prospects

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Atara Biotherapeutics Inc (ATRA) Q4 2019 Earnings Call Transcript

ATRA earnings call for the period ending December 31, 2019....…

Atara Biotherapeutics (ATRA) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Atara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q4 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Atara Biotherapeutics EPS misses by $0.05

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Recent Clinical, Operational and Strategic Progress

Company to host conference call today at 8:00 a.m. EST Company to host conference call today at 8:00 a.m. EST...…

Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2020 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic…

Atara Biotherapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 27, 2020

Live Conference Call and Webcast at 8:00 a.m. EST Live Conference Call and Webcast at 8:00 a.m. EST...…

Stock To Watch: Atara Biotherapeutics (ATRA)

Atara Biotherapeutics Inc. (ATRA) has some key milestones lined up for this year, making it a stock worth watching....…

Atara Biotherapeutics to Present 2020 Key Milestones and Progress in Bringing Off-The-Shelf, Allogeneic T-Cell Immunotherapies to Patients in Need at the 38th Annual J.P. Morgan Healthcare Conference

Key milestones anticipated across Ataras four strategic priorities in 2020...…

Atara Biotherapeutics Reports Updated Long-Term Clinical Results from a Tab-cel® Multicenter Expanded Access Protocol (EAP) Study for Patients with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) at the 61st Amer

61 patients with diverse EBV-associated diseases, including 26 relapsed/refractory EBV+ PTLD patients were treated in a multicenter tab-cel® (tabelecleucel) EAP…